Columbia Trust’s Amgen AMGN Stock Holding History

Columbia Trust’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$575K	Hold	1,997	–	–	0.26%	93
2023 Q3	$537K	Hold	1,997	–	–	0.31%	82
2023 Q2	$443K	Hold	1,997	–	–	0.25%	93
2023 Q1	$483K	Sell	1,997 -650	-25%	-$160K	0.28%	88
2022 Q4	$695K	Sell	2,647 -10	-0.4%	-$2.68K	0.39%	78
2022 Q3	$599K	Hold	2,657	–	–	0.34%	77
2022 Q2	$646K	Hold	2,657	–	–	0.35%	75
2022 Q1	$675K	Buy	2,657 +655	+33%	+$150K	0.32%	80
2021 Q4	$426K	Hold	2,002	–	–	0.23%	102
2021 Q3	$426K	Hold	2,002	–	–	0.22%	102
2021 Q2	$488K	Buy	2,002 +10	+0.5%	+$2.46K	0.28%	96
2021 Q1	$495K	Hold	1,992	–	–	0.31%	86
2020 Q4	$458K	Buy	+1,992	New	+$459K	0.32%	84
2020 Q2	$476K	Sell	2,022 -26	-1%	-$5.93K	0.42%	68
2020 Q1	$415K	Buy	2,048 +26	+1%	+$5.68K	0.45%	71
2019 Q4	$487K	Buy	+2,022	New	+$446K	0.43%	77

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Columbia Trust's AMGN Position: Q4 2023 in Review

Columbia Trust held its Amgen (AMGN) position steady in Q4 2023 at 1,997 shares worth $575K. The position accounts for 0.26% of the portfolio, ranked #93.

Columbia Trust first reported a position in AMGN in Q4 2019 and has held it in 16 quarters since. The position peaked at $695K in Q4 2022. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

Columbia Trust held 1,997 shares of Amgen worth $575K as of Q4 2023.
Columbia Trust left its Amgen share count unchanged in Q4 2023.
Amgen made up 0.26% of Columbia Trust's portfolio in Q4 2023, its #93 holding.
Columbia Trust first reported a position in Amgen in Q4 2019 and has held it in 16 quarters since.
Columbia Trust's Amgen position peaked at $695K in Q4 2022.
2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Columbia Trust's 13F filing for Q4 2023, filed 17 Jan 2024.